We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eli Lilly continued to beat back court challenges against Cymbalta, as a Virginia jury on Tuesday found the drugmaker not negligent in marketing its blockbuster antidepressant. Read More
The FDA is requiring manufacturers of DDP-4 inhibitors to add a label warning that the type 2 diabetes drugs may cause severe and disabling joint pain. Read More
The FDA may be reconsidering its policy of only requiring black box warnings on extended-release opioids, telling lawmakers that a citizen petition to require the same warnings for immediate-release opioids is under “active consideration.” Read More
The FDA is requiring additional warnings on the labeling of Leo Pharma’s Picato topical gel for actinic keratosis after receiving reports of severe allergic reactions and shingles associated with its use. Read More
Merck is recalling thousands of bottles of Temodar and temozolomide capsules, because cracks in the caps have rendered the child-resistant closure ineffective. Read More